Stanford professor Bryant Lin, a lung cancer researcher turned Stage IV patient, highlights targeted genetic therapies extending survival, insurance battles over costly drugs, and hope for personalized mRNA vaccines turning cancer into a manageable chronic disease.
Doctor Becomes Patient as Lung Cancer Treatment Advances
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →